Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs
about
mMass as a software tool for the annotation of cyclic peptide tandem mass spectraSelectivity and potency of microcystin congeners against OATP1B1 and OATP1B3 expressing cancer cellsBioprospecting marine planktonBiologically active secondary metabolites from marine cyanobacteriaExpression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets.High levels of structural diversity observed in microcystins from Microcystis CAWBG11 and characterization of six new microcystin congeners.Identification of inhibitors of biological interactions involving intrinsically disordered proteins.Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy.Hepatotoxic seafood poisoning (HSP) due to microcystins: a threat from the ocean?MTI-101 (cyclized HYD1) binds a CD44 containing complex and induces necrotic cell death in multiple myelomaThe chemistry and biology of organic guanidine derivatives.Cyanobacteria: potential candidates for drug discovery.Organic anion-transporting polypeptides: a novel approach for cancer therapy.Cyanobacteria and cyanotoxins: from impacts on aquatic ecosystems and human health to anticarcinogenic effects.Anticancer compounds from cyanobacterium Lyngbya species: a review.Cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells.Synthesis of Highly Selective Submicromolar Microcystin-Based Inhibitors of Protein Phosphatase (PP)2A over PP1.Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides.Baltic cyanobacteria – a source of biologically active compoundsTheoretical Study on Cyclopeptides as the Nanocarriers for Li+, Na+, K+and F−, Cl−, Br−
P2860
Q28483744-952222A3-23FE-4C3D-8223-5549F7AA8A74Q28540711-561F2B75-F01C-4710-8364-0A466FAAB98CQ28661272-9086AB7C-1B68-44D6-9CF2-8BB28E4289EEQ34554921-688367A2-D53F-4CB2-B06E-E5ABA076489CQ34883276-B806D7C3-C38A-4CAE-B43B-2DD5AF48CEE0Q35428374-C438AFE5-166F-4446-BDDC-80A67113832EQ35585498-D6E38F57-5C24-46EA-A87C-4355BCA98F5DQ36197335-82ADCB30-7040-40C0-8BEB-F8B2F63903DDQ36616448-81B2813A-4EA7-4C40-8AA3-65BAD9F69B75Q37155577-D8BF3D59-55D6-483B-910E-6CDEC68D3C38Q37385307-D3F153DD-B9DD-4ED7-B1A8-F92D9FA1239EQ38044691-10EC4A93-CEA7-4C54-9E7E-BD05724AAD9EQ38093448-87AB6203-5732-48EC-BF35-9920B658B4F5Q38132411-FE6DEEFC-33F1-4639-A141-93849A23FAD6Q38155037-30E57E3B-EDC9-4442-87E1-E8024ADC5E76Q38508840-108EACA0-2531-40DC-9FC5-D1294AC09A60Q39007306-ECE4827D-89E8-4B18-A4DC-8A29028EE2FAQ42366758-9B4F541A-605F-4596-AE23-B28A551E9428Q52646693-C7D44FAD-3790-4589-81C7-F241660A3D7DQ57265882-AF8A8939-95E9-4EED-BAF0-697741213CD0Q59113284-A07712B1-33BF-4AF6-9F36-6FD1C066F433
P2860
Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs
@ast
Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs
@en
type
label
Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs
@ast
Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs
@en
prefLabel
Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs
@ast
Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs
@en
P2093
P2860
P921
P356
P1433
P1476
Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs
@en
P2093
Andreas G Tzakos
Demosthenes Fokas
Evangelos Briasoulis
Ioannis Sainis
Katerina Vareli
Valentinos Kounnis
P2860
P304
P356
10.3390/MD8030629
P577
2010-03-15T00:00:00Z